CapsoVision CV
NASDAQ CV
$6.51 -0.18 (-2.69%)
As of: Sep 30, 2026 · 3:59 PM EDT

CapsoVision (CV) Current Deferred Revenue (2024 - 2026)

Updated

CapsoVision's Current Deferred Revenue came in at $140,000 for Q2 2026, up 44.3% from $97,000 a year earlier.

Analysis

CapsoVision (CV) Current Deferred Revenue (2024 - 2026) Analysis & Trends

At the end of FY2025, CapsoVision's Current Deferred Revenue was $177,000, up 34.1% from FY2024.

  • Going back by year, Current Deferred Revenue was $132,000 in FY2024.
  • The five-year range for quarterly Current Deferred Revenue is $97,000 (Q2 2025) to $177,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 CapsoVision 334.72 Mn 334.72 Mn 1.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140,000.00
Dec 31, 2025 177,000.00
Sep 30, 2025 106,000.00
Jun 30, 2025 97,000.00
Dec 31, 2024 132,000.00
API Access

CapsoVision Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CV&period=max&api_key=YOUR_API_KEY